Frederick C. Damen1, Changliang Su2, Burce Ozgen Mocan1, Tibor Vályi-Nagy3, Rifeng Jiang4, and Kejia Cai1,5
1Radiology, University of Illinois at Chicago, Chicago, IL, United States, 2Medical Imaging, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China, 3Pathology, University of Illinois at Chicago, Chicago, IL, United States, 4Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China, 5Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, United States
Synopsis
We present our
initial findings of applying Multimodal Apparent Diffusion (MAD)
MRI, including b-values up to 10,000 s/mm2, to analyze
subacute stroke lesions for the characterization of stroke lesions
based on micro-environment biomarkers in order to guide treatment in
clinics. MAD model is able to separate the acquired diffusion
weighted signal into flow, and, unimpeded
(fluid), hindered, and restricted apparent diffusion components.
Significant differences were found in MAD parameters between lesions
and normal appearing white matter. Fraction of unimpeded diffusion
significantly increased. Hindered
diffusion was significantly lower in lesions. On the other hand, restricted diffusion was
significantly higher.
Introduction
Ischemic stroke is the second most common cause of death and the
leading cause of acquired disability in adults[1,2]. Biomarkers are
needed to reflect relevant events in the ischemic cascade, from
cellular bioenergetic failure, through excitotoxicity, oxidative
stress, blood–brain barrier dysfunction, microvascular injury,
hemostatic activation, post-ischemic inflammation and finally cell
death of neurons, glial and endothelial cells[3]. There is a need to
improve the accuracy of stroke diagnosis and to more reliably predict
stroke outcome. Diffusion weighted MRI has long been used to detect
the onset of ischemic stroke. Albeit, there is still the quandary as
to when the ischemic cascade has progressed to the point that
recanalization would be ineffective and possibly damaging or lethal.
Herein we present our initial findings of applying Multimodal
Apparent Diffusion (MAD) MRI [4],
including b-values up to 10,000 s/mm2, to analyze
subacute stroke lesions in order to characterize stroke lesions based
on micro-environment biomarkers for the treatment guidance. MAD
methodology separates the acquired diffusion weighted signal from low
to high b values into flow, and unimpeded (fluid), hindered, and
restricted apparent diffusion components, providing their fractions
and diffusion coefficients.Methods
In an IRB approved study, 41 patients were imaged with confirmed
subacute stroke (25m/16f, 68±12yo)
with a total of 324 lesions. MAD images were acquired on a
Siemens/Prisma 3T MRI scanner with b-values (0/1, 500/1, 1000/1,
2000/2, 3000/2, 4000/3, 6000/3, 8000/4, 10,000/6 s/mm2
/averages) and acquisition/image matrix 128x128/256x256, FOV
230x230x5 mm, TR/TE 3900/69 ms, with an acquisition time of 3.7 min.
Diffusion weighted images were analyzed with the comprehensive MAD
method [4], which
separated the apparent diffusion contrast into, flow (>> 3 µm2
/ms), unimpeded diffusion (3 µm2/ms), hindered diffusion (> 0.1 & < 3 µm2/ms), and restricted diffusion (< 0.2 µm2/ms). ROIs were drawn based on the elevated signal on the
b=1000 s/mm2 image. ROIs were also drawn around normal
appearing white matter (NAWM). Student’s t-test was used to
compare the NAWM ROIs’ means with the means of lesion ROIs’ with
predominately homogeneous responses (n=238) the Hindered and
Restricted diffusion coefficients by using
p < 0.05 as statistical significance.Results
Figure 1 presents a example
of the MAD model parameters for lesions with predominately
homogeneous MAD parameter contrast. There were number of lesions
(n=86) with multiple regions of homogeneous MAD parameter contrast,
see figure 2 for an example. The lesions’ hindered diffusion
coefficients were significantly lower than that of NAWM and with a
wider variation, 0.86±0.095
µm2/ms,
0.90±0.040 µm2/ms, respectively, p<0.01, figure 3.
The lesions’ restricted diffusion coefficients were significantly
larger than that of NAWM and with a wider variation, 0.086±0.031
µm2/ms, 0.080±0.008 µm2/ms, respectively, p=0.01. The lesions’ fractions of
unimpeded diffusion (fluid) were significantly higher than that of
NAWM and with a wider variation, 12±9
percent, 10±3 percent,
respectively, p<0.01.Discussion
The reduced hindered diffusion coefficient in the stroke lesions are
consistent with cytotoxic edema associated with cellular bioenergetic
failure due to ischemia. The wider variation across
the lesions may be reflective of the varying degrees of ischemic
cascade progression. The lowering of the restricted diffusion
coefficient in lesions may be due to the excitotoxicity and
coagulative necrosis expelling the cellular contents into the
extracellular space. The multiple homogenous restricted diffusion
regions within heterotypic lesions may be reflective of the
neutrophils and/or macrophages processing the cellular debris, figure
2. The increase in the amount of unimpeded diffusion (fluid) and the
increased hindered diffusion coefficient in the lesions are
consistent with increased inflammation and necrosis, figure 4.Conclusion
By analyzing a wide spectrum of apparent diffusion covering b-value
from low to ultrahigh, multimodal apparent diffusion MRI helps to
characterize clinical subacute ischemic lesions. Investigations are
ongoing for further validations.Acknowledgements
No acknowledgement found.References
[1] Murray CJ, Lopez AD. Mortality by cause for eight regions of the
world: GlobalBurden of Disease Study. Lancet 1997;349:1269–76.
[2] Donnan GA,Fisher M,Macleod M,Davis SM. Stroke.
Lancet 2008;371:1612–23.
[3] Brouns R, De Deyn PP, The complexity of
neurobiological processes in acute ischemic stroke. Clinical
Neurology and Neurosurgery 111 (2009) 483–495
[4] Damen FC, Scotti A, Damen FW, Saran N,
Valyi-Nagy T, Vukelich M, Cai K. Multimodal apparent diffusion (MAD)
weighted magnetic resonance imaging. Magn Reson Imaging. 2021
Apr;77:213-233. doi: 10.1016/j.mri.2020.12.007. Epub 2020 Dec 10.
PMID: 33309925; PMCID: PMC7878401.